<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title></title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Diabetes and Its Complications</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <h4>Definition</h4>

            <p><strong>Diabetes</strong> is a multisystemic metabolic abnormality affecting metabolism of <strong>glucose</strong>, <strong>fat</strong>, <strong>protein</strong>, <strong>fluid</strong>, and <strong>electrolytes</strong> arising from absolute or relative deficiency of <strong>insulin</strong> of which chronic <strong>hyperglycemia</strong> is the <em>sin qua non</em>.</p>
            
            <p><strong>Diabetes</strong> is a significant and growing threat to global health. Worldwide, <strong>diabetes</strong> affects <strong>417 million people</strong> in 2017, the world prevalence is predicted to reach <strong>620 million</strong> by <strong>2040</strong>. The developing countries are more likely to be affected.</p>
            
            <p><strong>Type 2</strong> constitutes ‚âà <strong>70-90%</strong> and <strong>type 1</strong> ‚âà <strong>1-10%</strong> <strong>diabetes</strong> among Northern Europe.</p>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Diagnosis</a>
          </h2>
        </header>
        <div class='body'>
            <p>
                The presence of typical features of the disease:
                <ul>
                  <li><strong>polyphagia</strong>,</li>
                  <li><strong>polydipsia</strong>,</li>
                  <li><strong>polyuria</strong>,</li>
                  <li>and weight loss with either:</li>
                </ul>
                <ul>
                  <li><strong>FBS</strong> ‚â• <strong>126mg/dl</strong> (<strong>7.0mmol/L</strong>), or</li>
                  <li><strong>RBS</strong> ‚â• <strong>200mg/dl</strong> (<strong>11.1mmol/L</strong>), or</li>
                  <li><strong>HbA1c</strong> ‚â• <strong>6.5%</strong> (<strong>48mmol/mol</strong>).</li>
                </ul>
              </p>
              
              <p>
                Absence of symptoms, 
                <strong>RBS</strong> ‚â• <strong>200mg/dl</strong> (<strong>11.1mmol/L</strong>). 
                You have to do 
                <ul>
                  <li><strong>FBS</strong> or</li>
                  <li><strong>HbA1c</strong>,</li>
                </ul>
                and if above the aforementioned.
              </p>
              
              <p>
                Absence of symptoms but 
                <ul>
                  <li><strong>FBS</strong> = <strong>100mg/dL</strong> - <strong>125mg/dL</strong> (<strong>5.6</strong> to <strong>6.9mmol/l</strong>)</li>
                  <li><strong>RBS</strong> = <strong> 140-199mg/dL</strong> (<strong>7.8-11mmol/L</strong>)</li>
                  <li><strong>HbA1c</strong> = <strong>5.7-6.4%</strong> (<strong>38-47mmol/mol</strong>)</li>
                </ul>
                = Intermediate glycemia will go for OGTT. If found to be as 1, then diagnosed.
              </p>
              
              

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Types of Diabetes based on Etiology</a>
          </h2>
        </header>
        <div class='body'>

            <ol type="I">
              <li><strong>Type 1 diabetes</strong> (immune-mediated beta cell destruction, usually leading to absolute insulin deficiency)</li>
              <li><strong>Type 2 diabetes</strong> (may range from predominantly insulin resistance with relative insulin deficiency to a predominantly insulin secretory defect with insulin resistance)</li>
              <li><strong>Specific types of diabetes</strong>
                <ol type="A">
                  <li>Genetic defects of beta cell development or function characterized by mutations in:
                    <ol type="1">
                      <li>Hepatocyte nuclear transcription factor (HNF) 4Œ± (MODY 1)</li>
                      <li>Glucokinase (MODY 2)</li>
                      <li>HNF-1Œ± (MODY 3)</li>
                      <li>Insulin promoter factor-1, HNF-1Œ≤, NeuroD1, and others leading to other forms of MODY</li>
                      <li>Insulin, subunits of ATP-sensitive potassium channel leading to permanent neonatal diabetes</li>
                      <li>Mitochondrial DNA</li>
                      <li>Other pancreatic islet regulators/proteins such as KLF11, PAX4, BLK, GATA4, GATA6, SLC2A2 (GLUT2), RFX6, GLIS3</li>
                    </ol>
                  </li>
                  <li>Transient neonatal diabetes</li>

                  <li>Diseases of the exocrine pancreas‚Äîpancreatitis, pancreatectomy, neoplasia, cystic fibrosis, hemochromatosis, fibrocalculous pancreatopathy, mutations in carboxyl ester lipase</li>
                  <li>Genetic defects in insulin action, including type A insulin resistance, Leprechaunism, Rabson-Mendenhall syndrome, Lipodystrophy syndromes</li>
                  <li>Endocrinopathies‚Äîacromegaly, Cushing‚Äôs syndrome, glucagonoma, pheochromocytoma, hyperthyroidism, somatostatinoma, aldosteronoma</li>
                  <li>Drug- or chemical-induced‚Äîglucocorticoids, vacor (a rodenticide), pentamidine, nicotinic acid, diazoxide, Œ≤-adrenergic agonists, thiazides, calcineurin and mTOR inhibitors, hydantoins, asparaginase, Œ±-interferon, protease inhibitors, antipsychotics (atypicals and others), epinephrine</li>
                  <li>Infections‚Äîcongenital rubella, cytomegalovirus, coxsackievirus</li>

                    <li>Uncommon forms of immune-mediated diabetes‚Äî‚Äústiff-person‚Äù syndrome, anti-insulin receptor antibodies</li>
                    <li>Other genetic syndromes sometimes associated with diabetes‚ÄîWolfram‚Äôs syndrome, Down‚Äôs syndrome, Klinefelter‚Äôs syndrome, Turner‚Äôs syndrome, Friedreich‚Äôs ataxia, Huntington‚Äôs chorea, Laurence-Moon-Biedl syndrome, myotonic dystrophy, porphyria, Prader-Willi syndrome</li>
                  </ol>
              </li>
              <li><strong>Gestational diabetes mellitus (GDM)</strong></li>

            </ol>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Risk factors for Type 2 Diabetes</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>Family history of diabetes (i.e., parent or sibling with Type 2 Diabetes)</li>
              <li>Overweight or obese (BMI ‚â• <strong>25 kg/m<sup>2</sup></strong>, ‚â• <strong>23 kg/m<sup>2</sup></strong> in Asian Americans, or other ethnically relevant definition for overweight)</li>
              <li>Physical inactivity</li>
              <li>Race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander)</li>
              <li>Previously identified with IFG, IGT, or a hemoglobin A1c of <strong>5.7‚Äì6.4%</strong></li>
              <li>History of GDM (Gestational Diabetes Mellitus)</li>
              <li>Hypertension (blood pressure ‚â• <strong>140/90 mmHg</strong>)</li>
              <li>HDL cholesterol level <strong>&lt;35 mg/dL</strong> (<strong>0.90 mmol/L</strong>) and/or a triglyceride level <strong>&gt;250 mg/dL</strong> (<strong>2.82 mmol/L</strong>)</li>
              <li>Polycystic ovary syndrome or acanthosis nigricans</li>
              <li>History of cardiovascular disease</li>
            </ul>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Differences between Type 1 and 2</a>
          </h2>
        </header>
        <div class='body'>

            <br>

            <table class="note-table">
              <thead>
                <tr>
                  <th></th>
                  <th>Features</th>
                  <th>Type 1</th>
                  <th>Type 2</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>1</td>
                  <td>Frequency</td>
                  <td>10%-20%</td>
                  <td>80%-90%</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td>Age of onset</td>
                  <td>Early, <35 y</td>
                  <td>Late, >40 y</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td>Type of onset</td>
                  <td>Abrupt and severe</td>
                  <td>Gradual and insidious</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td>Weight</td>
                  <td>Normal</td>
                  <td>Obese or nonobese</td>
                </tr>
                <tr>
                  <td>5</td>
                  <td>HLA</td>
                  <td>Linked to HLA DR3, HLA DR4, HLA DQ</td>
                  <td>No HLA association</td>
                </tr>
                <tr>
                  <td>6</td>
                  <td>Family history</td>
                  <td> &lt; 20%</td>
                  <td>Approximately 60% </td>
                </tr>
                <tr>
                  <td>7</td>
                  <td>Genetic locus</td>
                  <td>Unknown</td>
                  <td>Chromosome 6</td>
                </tr>
                <tr>
                  <td>8</td>
                  <td>Diabetes in identical twins</td>
                  <td>50% concordance</td>
                  <td>80% concordance</td>
                </tr>
                <tr>
                  <td>9</td>
                  <td>Pathogenesis</td>
                  <td>Autoimmune destruction of Œ≤ cells</td>
                  <td>Insulin resistance impaired insulin secretion</td>
                </tr>
                <tr>
                  <td>10</td>
                  <td>Islets of cell antibodies</td>
                  <td>Yes</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>11</td>
                  <td>Blood insulin level</td>
                  <td>Decreased insulin</td>
                  <td>Normal or increased insulin</td>
                </tr>
                <tr>
                  <td>12</td>
                  <td>Islet-cell changes</td>
                  <td>Insulin cell depletion</td>
                  <td>No insulitis, later fibrosis</td>
                </tr>
                <tr>
                  <td>13</td>
                  <td>Amyloidosis</td>
                  <td>Infrequent</td>
                  <td>Common in chronic cases</td>
                </tr>
                <tr>
                  <td>14</td>
                  <td>Clinical management</td>
                  <td>Insulin, diet</td>
                  <td>Diet, exercise, oral drugs, insulin</td>
                </tr>
                <tr>
                  <td>15</td>
                  <td>Acute complications</td>
                  <td>Ketoacidosis</td>
                  <td>Hyperosmolar coma</td>
                </tr>
                </tbody>
                <tr>
                  <td colspan="4"> 
                    <ul>
                      <li>HLA, human leukocyte antigen</li>
                    </ul>
                  </td>
                </tr>
            </table>
            
              
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Treatment</a>
          </h2>
        </header>
        <div class='body'>
            <h4></h4>

            <ul>
              <li><strong>CBC-ESR</strong>, <strong>E</strong>, <strong>U</strong>, <strong>Cr</strong>, <strong>Ca</strong>, <strong>Phosp</strong>, <strong>ECG</strong>, <strong>Echo</strong>, <strong>FLP</strong>, <strong>LFT</strong>, <strong>Abd-pelvis Uss</strong>, <strong>Early morning urine sediment for microscopy</strong>, <strong>Urinalysis</strong>, <strong>FBS</strong>, <strong>RBS/2Hrpp</strong>, <strong>HbA1c</strong></li>
              <li>Healthy diet/ Regular exercise</li>
              <li>Drugs
                <ul>
                  <li><strong>Insulin</strong>: short/fast acting, intermediate, premixed, long acting</li>
                  <li>Oral drugs: 
                    <ul>
                      <li>Sulphonylureas</li>
                      <li>Biguanides</li>
                      <li>Alpha glucosidase inhibitors</li>
                      <li>Thiazolidinediones</li>
                      <li>Dipeptidyl peptidase-4 (DPP-4) inhibitors</li>
                      <li>Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists)</li>
                      <li>Meglitinides</li>
                      <li>Sodium-glucose transporters  </li>
                      <li>Others
                        <ul>
                          <li>Dopamine agonist</li>
                          <li>Amylinomimetic drug</li>
                        </ul>
                      </li>
                    </ul>
                  </li>
                </ul>
              </li>
              <li>Blood pressure drugs, antiplatelets, cholesterol drugs</li>
            </ul>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Complications of Diabetes Mellitus - Acute </a>
          </h2>
        </header>
        <div class='body'>
            <h4></h4>

            <ul>
              <li>Hypoglycemia</li>
              <li>Ketoacidosis</li>
              <li>Hyperglycemia hyperosmolar state</li>
              <li>Uremic acidosis</li>
              <li>Lactic acidosis</li>
            </ul>
            
<br>
            <table class="note-table">
                <tr>
                    <th colspan="3" style="text-align: center;">Differences between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)</th>
                </tr>
              <tr>
                <th></th>
                <th>DKA</th>
                <th>HHS</th>
              </tr>
              <tr>
                <td><strong>Glucose, mmol/L (mg/dL)</strong></td>
                <td>13.9‚Äì33.3 (250‚Äì600)</td>
                <td>33.3‚Äì66. (600‚Äì1200)</td>
              </tr>
              <tr>
                <td><strong>Sodium, meq/L</strong></td>
                <td>125‚Äì135</td>
                <td>135‚Äì145</td>
              </tr>
              <tr>
                <td><strong>Potassium</strong></td>
                <td>Normal to ‚Üë</td>
                <td>Normal</td>
              </tr>
              <tr>
                <td><strong>Creatinine</strong></td>
                <td>Slightly ‚Üë</td>
                <td>Moderately ‚Üë</td>
              </tr>
              <tr>
                <td><strong>Osmolality (mosm/mL)</strong></td>
                <td>300‚Äì320</td>
                <td>330‚Äì380</td>
              </tr>
              <tr>
                <td><strong>Plasma ketones</strong></td>
                <td>++++</td>
                <td>+/-</td>
              </tr>
              <tr>
                <td><strong>Serum bicarbonate, meq/L</strong></td>
                <td>&lt;15</td>
                <td>Normal to slightly ‚Üì</td>
              </tr>
              <tr>
                <td><strong>Arterial pH</strong></td>
                <td>6.8‚Äì7.3</td>
                <td>&gt;7.3</td>
              </tr>
              <tr>
                <td><strong>Arterial PCO, mmHg</strong></td>
                <td>20‚Äì30</td>
                <td>Normal</td>
              </tr>
              <tr>
                <td><strong>Anion gap (Na ‚Äì [Cl + HCO3])</strong></td>
                <td>‚Üë</td>
                <td>Normal to slightly ‚Üë</td>
              </tr>
            </table>


            
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'> Complications of Diabetes Mellitus - Chronic</a>
          </h2>
        </header>
        <div class='body'>


            <h4>A. Microvascular</h4>
            <ol>
              <li>
                Eye disease
                <ul>
                  <li>Retinopathy (nonproliferative/proliferative)</li>
                  <li>Macular edema</li>
                </ul>
              </li>
              <li>
                Neuropathy
                <ul>
                  <li>Sensory and motor (mono- and polyneuropathy)</li>
                  <li>Autonomic</li>
                </ul>
              </li>
              <li>Nephropathy (albuminuria and declining renal function)</li>
            </ol>
            
            <h4>B. Macrovascular</h4>
            <ol>
              <li>Coronary heart disease</li>
              <li>Peripheral arterial disease</li>
              <li>Cerebrovascular disease</li>
            </ol>
            
            <h4>Chronic Complications of Diabetes - Other</h4>

            <ul>
              <li>Gastrointestinal (gastroparesis, diarrhea)</li>
              <li>Genitourinary (uropathy/sexual dysfunction)</li>
              <li>Dermatologic</li>
              <li>Infectious</li>
              <li>Cataracts</li>
              <li>Glaucoma</li>
              <li>Cheiroarthropathy (Thickened skin and reduced joint mobility)</li>
              <li>Periodontal disease</li>
              <li>Hearing loss</li>
              <li>Other comorbid conditions associated with diabetes (relationship to hyperglycemia is uncertain): depression, obstructive sleep apnea, fatty liver disease, hip fracture, osteoporosis (in type 1 diabetes), cognitive impairment or dementia, low testosterone in men.</li>
            </ul>
            
            <h4>Pathogenesis of Chronic Diabetes Mellitus Complications</h4>

            <ul>
              <li>Glycation of proteins and macromolecules</li>
              <li>Overactivity of the polyol pathway</li>
              <li>Activation of protein kinase C</li>
              <li>Abnormal microvascular blood flow</li>
            </ul>
            
        </div>
      </section>








      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
